Kuros Biosciences AG (SWX:KURN)

Market Cap	932.91M
Revenue (ttm)	103.35M
Net Income (ttm)	-6.07M
Shares Out	38.61M
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	161.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	268,885
Average Volume	149,450
Open	24.12
Previous Close	24.16
Day's Range	24.12 - 25.48
52-Week Range	14.00 - 32.00
Beta	0.61
RSI	56.84
Earnings Date	Mar 10, 2026

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bon...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 122
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: KURN

Financial Performance

In 2024, Kuros Biosciences AG's revenue was 75.56 million, an increase of 125.11% compared to the previous year's 33.56 million. Losses were -4.29 million, -68.75% less than in 2023.